Showing results 1 to 20 of 24
next >
| Preview | Issue Date | Title / Name | Author(s) | Type |
 | May-2024 | 233P Real-world first-line (1L) treatment selection for Australian patients (pts) with hormone receptor-positive advanced breast cancer (HR+ ABC) | Wong, V.; Baron-Hay, S.E.; De Boer, R.H.; Boyle, F.; Collins, Ian M., et al | Conference Paper | |
| 2019 | A Victorian clinician-based survey on current practices for breast cancer staging in pregnancy | Herbison, Harriet; Miller, Abigail; Hart, Christopher D.; Hayes, Theresa M.; Shnier, Darryl, et al | Conference Paper | |
| 2020 | Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer | Loft, Matthew; Lok, Sheau Wen; De Boer, Richard H.; Malik, Laeeq; Greenberg, Sally, et al | Journal Article | |
| Jan-2023 | Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer | Loft, Matthew; Lok, Sheau Wen; De Boer, Richard; Malik, Laeeq; Greenberg, Sally, et al | Journal Article | |
| 2014 | Assessing and managing breast cancer risk: Clinicians' current practice and future needs | Collins, Ian M.; Steel, Emma; Mann, G Bruce; Emery, Jon D.; Bickerstaffe, Adrian, et al | Journal Article | |
 | Jan-2023 | Breast cancer specialists’ experiences and attitudes towards mainstream genetic testing for patients with breast cancer | Allan, Kirsten; Cicciarelli, Linda; Beard, Catherine; Linderman, Geoffrey J.; Mann, G Bruce, et al | Journal Article | |
| 2022 | CDK4/6 Inhibitors (CKD4/6i) in advanced hormone-receptor-positive (HR+) HER2-negative (HER2-) breast cancer: Prescribing practices and outcomes in a real-world, Australian cohort | Javaid, Anadil; Lok, Sheau Wen; Wong, Vanessa; Baron-Hay, Sally; Boyle, Fran, et al | Conference Paper | |
| 2016 | How do average woman think about breast cancer risk and prevention? | Keogh, Louise A.; Steel, Emma; Weideman, Prue; Butow, Phyllis; Collins, Ian M., et al | Conference Paper | |
 | 2017 | Influence of socioeconomic factors and distance to radiotherapy on breast-conserving surgery rates for early breast cancer in regional Australia; implications of change | Lum, Caroline; Collins, Ian M.; Versace, Vincent L.; Collins, Ian M. | Journal Article | |
 | 2016 | iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management | Collins, Ian M.; Bickerstaffe, Adrian; Ranaweera, Thilina; Maddumarachchi, Sanjaya; Keogh, Louise, et al | Journal Article | |
| 2020 | P7 Are women commencing Neoadjuvant Chemotherapy (NAC) for Primary Breast Cancer (PBC) more likely to experience distress compared to women undergoing surgical intervention or Adjuvant Chemotherapy (AC)? | Hay, R. L.; Pascoe, E.; Hay, Rebecca | Conference Paper | |
| 31-May-2023 | Real world evidence of systemic therapy in hormone receptor positive advanced breast cancer (HR+ ABC) in Australia: ARORA Registry. | Wen Lok, Sheau; Tung, Iris; Anton, Angelyn; Baron-Hay, Sally E.; De Boer, Richard H., et al | Conference Paper | |
| 2020 | Real world outcomes in elderly patients with HER2 positive advanced breast cancer | Evans, Nicole; Anton, Angelyn; Wong, Rachel; Lok, Sheau Wen; De Boer, Richard, et al | Conference Paper | |
 | 2020 | Real World Outcomes in Elderly Women with HER2-Positive Advanced Breast Cancer | Evans, Nicole; Anton, Angelyn; Wong, Rachel; Lok, Sheau Wen; De Boer, Richard, et al | Conference Paper | |
| 2020 | Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer | Conduit, C.; de Boer, R. H.; Lok, S.; Gibbs, Peter; Malik, Laeeq, et al | Journal Article | |
| 2020 | Real-world uptake of bone modifying agents in advanced breast cancer with bone metastases-Prospective data from a multi-site Australian registry | Wong, Vanessa; De Boer, Richard; Anton, Angelyn; Malik, Laeeq; Greenberg, Sally, et al | Conference Paper | |
| 11-Sep-2023 | Ribociclib may potentiate rosuvastatin effect in causing late onset rhabdomyolysis | Teo, Siaw Wee; Hayes, Theresa M.; Gome, James, J.; Teo, Siaw Wee; Hayes, Theresa M., et al | Journal Article | |
 | 2007 | Severe palmar-plantar erythema in a patient with breast cancer receiving doxorubicin-cyclophosphamide Chemotherapy | Damasiewicz, M. J.; Chionh, F. J. M.; Hayes, Theresa M.; Hayes, Theresa M. | Journal Article | |
| 2015 | Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer (BC). | Khasraw, Mustafa; Mukaro, Violet; West, Linda; Brandt, Conrad; Woollett, Anne Maree, et al | Conference Paper | |
 | 2019 | Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial-Clinical outcomes and molecular determinants of response | Murphy, Caitlin; Muscat, Andrea; Ashley, David; Mukaro, Violet; West, Linda, et al | Journal Article | |
